Abstract
OBJECTIVE: To study whether weight reducing treatment modulates serum concentration of TNF-α and two soluble TNF-α receptors in obese subjects.
SUBJECTS AND MEASUREMENTS: Serum concentrations of TNF-α and two soluble receptors (sTNF-R1, sTNF-R2), plasma glucose, insulin, total cholesterol, HDL-cholesterol and triglicerides were measured in 27 obese subjects (age 48±12 y, body mass index (BMI): 36±6 kg/m2) before and after 3 months weight reducing treatment consisted of a diet & 1000 kcal/day and physical exercises.
RESULTS: The mean loss of weight during 3 months' treatment was 9.3±3.3 kg. The serum concentration of TNF-α decreased after weight loss and at the same time both of the receptors (sTNF-R1,sTNF-R2) increased significantly.
CONCLUSION: The observed decrease of the serum concentration of TNF-α and the increase in both TNF soluble receptors after weight reducing treatment in obese subjects, may be a counter-regulation preventing further weight loss.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM . Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance J Clin Invest 1995 95: 2409–2415.
Hauner H, Bender M, Haastert B, Hube F . Plasma concentrations of soluble TNF-alpha receptors in obese subjects Int J Obes Relat Metab Disord 1998 22: 1239–1243.
Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW . Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-a in vivo J Clin Endocrinol Metab 1997 82: 4196–4200.
Hotamisligil GS, Budavari A, Murray D, Spiegelman BM . Reduced tyrosine kinase activity of the insulin receptor in obesity–diabetes. Central role of tumor necrosis factor-α J Clin Invest 1994 94: 1543–1549.
Spiegelman BM, Hotamisligil GS . Through thick and thin: wasting, obesity, and TNFα Cell 1993 73: 625–627.
Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM . Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance Endocrinology 1994 134: 264–270.
Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB . The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase J Clin Invest 1995 95: 2111–2119.
Skolnik EY, Marcusohn J . Inhibition of insulin receptor signaling by TNF: potential role of obesity and non-insulin-dependent diabetes mellitus Cytokine Growth Factor Rev 1996 7: 161–173.
Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D . Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis Eur J Haematol 1995 54: 1–8.
Hube F, Rohrig K, Hauner H . Overexpression of both TNF receptors in human obesity Int J Obes Relat Metab Disord 1997 21 (Suppl 2): S130.
Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, Majewski T . Serum concentration of tumor necrosis factor in obese women J Endocrinol Invest 1999 22 (Suppl to no. 7): 66.
Corica F, Allegra A, Corsonello A, Buemi M, Calapai G, Ruello A, Nicita Mauro V, Ceruso D . Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects Int J Obes Relat Metab Disord 1999 23: 355–360.
Uysal KT, Wiesbrock SM, Hotamisligil GS . Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity Endocrinology 1998 139: 4832–4838.
Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T . Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss J Clin Endocrinol Metab 1998 83: 2907–2910.
Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y . Serum levels of tumor necrosis factor alpha are increased in obese patients with noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 1998 83: 859–862.
Bastard JP, Hainque B, Dusserre E, Bruckert E, Robin D, Vallier P, Perche S, Robin P, Turpin G, Jardel C, Laville M, Forest C, Vidal H . Peroxisome proliferator activated receptor-gamma, leptin and tumor necrosis factor-alpha mRNA expression during very low calorie diet in subcutaneous adipose tissue in obese women Diabetes Metab Res Rev 1999 15: 92–98.
Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM . Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance Diabetes 1997 46: 451–455.
Fernandez-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, Vendrell J, Richart C . Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance Diabetes 1998 47: 1757–1762.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zahorska-Markiewicz, B., Janowska, J., Olszanecka-Glinianowicz, M. et al. Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obes 24, 1392–1395 (2000). https://doi.org/10.1038/sj.ijo.0801398
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801398
Keywords
This article is cited by
-
The 24-h profile of the DNA repair enzyme 8-oxoguanine glycosylase 1 (OGG1) is associated with age, TNF-α, and waist circumference in healthy adults
GeroScience (2023)
-
Breast cancer microenvironment and obesity: challenges for therapy
Cancer and Metastasis Reviews (2022)
-
Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension
Cardiovascular Diabetology (2021)
-
The fatty acid profile of adipose tissue as a predictor of the ponderal and inflammatory response in adult women six years after bariatric surgery
Lipids in Health and Disease (2020)
-
Effects of oral Nigella sativa oil on the expression levels and serum concentrations of adiponectin, PPAR-γ, and TNF-α in overweight and obese women: a study protocol for a crossover-designed, double-blind, placebo-controlled randomized clinical trial
Trials (2019)